HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshito Abe Selected Research

Yoshito Abe Research Topics

Disease

4Immunoglobulin Light-chain Amyloidosis
12/2022 - 10/2009
4Neuralgia (Stump Neuralgia)
01/2022 - 03/2013
3Neoplasms (Cancer)
01/2021 - 01/2019
2Amyloidosis
12/2018 - 04/2013
1Osteoporosis
01/2021
1Astrocytoma (Pilocytic Astrocytoma)
01/2019
1Scrapie
12/2013
1Peripheral Nerve Injuries
03/2013
1Hyperalgesia
03/2013
1Thrombosis (Thrombus)
11/2002

Drug/Important Bio-Agent (IBA)

4Amyloid (Amyloid Fibrils)IBA
12/2022 - 10/2009
4Purinergic P2X4 ReceptorsIBA
01/2022 - 03/2013
4Monoclonal AntibodiesIBA
01/2022 - 03/2013
2Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2013
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
12/2022 - 10/2009
1isoquercitrinIBA
12/2022
1gossypetinIBA
12/2022
1RANK LigandIBA
01/2021
1DenosumabFDA Link
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1AntibodiesIBA
01/2019
1QuinazolinesIBA
01/2019
1Catechin (Z 7300)IBA
12/2018
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2018
1TeaIBA
12/2018
1Adenosine Diphosphate (ADP)IBA
12/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2013
1Adenosine Triphosphate (ATP)IBA
12/2013
1Glucose (Dextrose)FDA LinkGeneric
04/2013
1SugarsIBA
04/2013
1Peptides (Polypeptides)IBA
04/2013
1Sucrose (Saccharose)IBA
04/2013
1TrehaloseIBA
04/2013
1Purinergic Receptors (Receptors, Purine)IBA
03/2013
1Factor V (Coagulation Factor V)IBA
11/2002

Therapy/Procedure

2Immunotherapy
01/2021 - 10/2019
1Oral Administration
01/2019